SCHEMBL6436941

SCHEMBL6436941

COC(=O)c1cc(C(=O)O)ccc1-c1cccc([N+](=O)[O-])c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.54
SLC6A4 P31645 1/20 0.51
AKR1C3 P42330 4/20 0.50
AKR1C2 P52895 4/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 2/20 0.50
CSNK2A1 P68400 2/20 0.47
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
GAA P10253 1/20 0.46
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46
TUBB3 Q13509 1/20 0.46
TUBB2A Q13885 1/20 0.46
TUBB8 Q3ZCM7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6434542 0.93 MEN1 (0.54) SLC6A4AKR1C3AKR1C2MEN1KMT2A
SCHEMBL31120368 0.87 TP53 (0.62) TP53AKR1C3AKR1C2ALDH1A1CSNK2A1
SCHEMBL6432585 0.83 SLC6A4 (0.56) SLC6A4AKR1C3AKR1C2MEN1KMT2A
SCHEMBL29441710 0.83 SLC6A4 (0.56) SLC6A4AKR1C3AKR1C2MEN1KMT2A
SCHEMBL15229768 0.82 MYC (0.55) TP53SLC6A4MEN1KMT2AALDH1A1
SCHEMBL1569116 0.81 EGFR (0.57) TP53SLC6A4MEN1KMT2AALDH1A1
SCHEMBL27086380 0.81 SLC6A4 (0.49) SLC6A4AKR1C3AKR1C2MEN1KMT2A
SCHEMBL6852757 0.80 TP53 (0.64) TP53AKR1C3AKR1C2CSNK2A1KEAP1
SCHEMBL6434824 0.80 MAPT (0.49) TP53SLC6A4MEN1KMT2AALDH1A1
SCHEMBL22336247 0.79 KDM4E (0.53) SLC6A4AKR1C3AKR1C2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087943-B1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LTD (GB) 2005-08-17 EP disclosed
US-6251925-B1 AN AGONISTS FOR HUMAN BETA-3 ADRENOCEPTOR GLAXO WELLCOME INC. 2001-06-26 US disclosed
EP-1087943-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 2001-04-04 EP disclosed
WO-1999065877-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 1999-12-23 WO disclosed